-
公开(公告)号：EP1682549B1
公开(公告)日：2010-09-22
申请号：EP04796657.7
申请日：2004-10-28
申请人： Sepracor Inc. , Fang, Kevin , Grover, Paul , Jerussi, Tom
发明人： FANG, Kevin , GROVER, Paul , JERUSSI, Tom
IPC分类号： C07D471/04 , A61K31/435 , A61P25/00
CPC分类号： A61K31/435 , C07D471/04
摘要： Imidazo[1,2-a]apyridines of the formulae I and II: are disclosed. The compounds are useful to treat anxiety and insomnia. Pharmaceutical compositions and methods are also disclosed. A representative compound of the invention is:
-
公开(公告)号：EP1682549A2
公开(公告)日：2006-07-26
申请号：EP04796657.7
申请日：2004-10-28
申请人： Sepracor Inc. , Fang, Kevin , Grover, Paul , Jerussi, Tom
发明人： FANG, Kevin , GROVER, Paul , JERUSSI, Tom
IPC分类号： C07D471/04
CPC分类号： A61K31/435 , C07D471/04
摘要： Imidazo[1,2-a]apyridines of the formulae I and II: are disclosed. The compounds are useful to treat anxiety and insomnia. Pharmaceutical compositions and methods are also disclosed. A representative compound of the invention is:
-
公开(公告)号：EP1259243B2
公开(公告)日：2010-07-21
申请号：EP00957684.4
申请日：2000-08-23
申请人： SEPRACOR, INC.
IPC分类号： A61K31/5375 , A61K31/137 , A61P25/24 , A61P25/34 , A61P25/20
CPC分类号： A61K31/537 , A61K31/00 , A61K31/135 , A61K31/137 , A61K31/165 , A61K31/415 , A61K31/43 , A61K31/435 , A61K31/46 , A61K31/465 , A61K31/50 , A61K31/53 , A61K31/535 , A61K31/5375 , A61K45/06 , C07B2200/07 , C07C45/511 , C07C45/63 , C07C49/84 , C07C69/76 , C07C213/00 , C07C215/30 , C07C225/16 , C07D265/32 , A61K2300/00 , C07C49/82 , C07C49/80
摘要： Methods and compositions are disclosed which utilize metabolites of bupropion for treating disorders ameliorated by inhibition of neuronal monoamine reuptake. Such disorders include, but are not limited to, sexual dysfunction, affective disorders, cerebral function disorders, cigarette smoking, and incontinence. Methods of making optically pure bupropion metabolites are also disclosed.
-
公开(公告)号：EP1259243B1
公开(公告)日：2006-06-28
申请号：EP00957684.4
申请日：2000-08-23
申请人： SEPRACOR, INC.
IPC分类号： A61K31/5375 , A61K31/137 , A61P25/24 , A61P25/34 , A61P25/20
CPC分类号： A61K31/537 , A61K31/00 , A61K31/135 , A61K31/137 , A61K31/165 , A61K31/415 , A61K31/43 , A61K31/435 , A61K31/46 , A61K31/465 , A61K31/50 , A61K31/53 , A61K31/535 , A61K31/5375 , A61K45/06 , C07B2200/07 , C07C45/511 , C07C45/63 , C07C49/84 , C07C69/76 , C07C213/00 , C07C215/30 , C07C225/16 , C07D265/32 , A61K2300/00 , C07C49/82 , C07C49/80
摘要： Methods and compositions are disclosed which utilize metabolites of bupropion for treating disorders ameliorated by inhibition of neuronal monoamine reuptake. Such disorders include, but are not limited to, sexual dysfunction, affective disorders, cerebral function disorders, cigarette smoking, and incontinence. Methods of making optically pure bupropion metabolites are also disclosed.
-
公开(公告)号：EP1259243A2
公开(公告)日：2002-11-27
申请号：EP00957684.4
申请日：2000-08-23
申请人： SEPRACOR, INC.
IPC分类号： A61K31/5375 , A61K31/137 , A61P25/24 , A61P25/34 , A61P25/20
CPC分类号： A61K31/537 , A61K31/00 , A61K31/135 , A61K31/137 , A61K31/165 , A61K31/415 , A61K31/43 , A61K31/435 , A61K31/46 , A61K31/465 , A61K31/50 , A61K31/53 , A61K31/535 , A61K31/5375 , A61K45/06 , C07B2200/07 , C07C45/511 , C07C45/63 , C07C49/84 , C07C69/76 , C07C213/00 , C07C215/30 , C07C225/16 , C07D265/32 , A61K2300/00 , C07C49/82 , C07C49/80
摘要： Methods and compositions are disclosed which utilize metabolites of bupropion for treating disorders ameliorated by inhibition of neuronal monoamine reuptake. Such disorders include, but are not limited to, sexual dysfunction, affective disorders, cerebral function disorders, cigarette smoking, and incontinence. Methods of making optically pure bupropion metabolites are also disclosed.
-
-
-
-
搜索结果
5 条记录 (耗时 0.017 秒)
